{"id":1107,"date":"2024-10-30T13:41:53","date_gmt":"2024-10-30T13:41:53","guid":{"rendered":"https:\/\/haemophilia.org.ls\/wordpress\/?page_id=1107"},"modified":"2024-11-11T14:09:51","modified_gmt":"2024-11-11T14:09:51","slug":"outreach","status":"publish","type":"page","link":"https:\/\/haemophilia.org.ls\/index.php\/outreach\/","title":{"rendered":"Outreach"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t

OUTREACH<\/h1>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

As part of its commitment to improving the lives of individuals affected by hemophilia, HAL has implemented a series of targeted initiatives aimed at enhancing access to education and healthcare resources. These programs are designed to address the unique challenges faced by patients with hemophilia, healthcare professionals (HCPs), and other key stakeholders, particularly those in underserved communities. By providing critical information, resources, and training, HAL seeks to improve health literacy, support better disease management, and ensure that individuals with hemophilia receive the care and interventions necessary to optimize their health outcomes and quality of life.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\"KODAK\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t

PATIENT OUTREACH<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

HAL\u2019s patient outreach initiatives are designed to improve the care and quality of life for individuals with hemophilia, with a focus on comprehensive support for both patients and their families. Key components of the program include:<\/p>

1.Family Pedigree Assessment:<\/strong> <\/em>HAL conducts detailed family pedigree assessments to identify genetic patterns of hemophilia, enabling early diagnosis and tailored care plans for affected individuals and at-risk family members.<\/p>

2.Clinical Visits:<\/strong> <\/em>HAL organizes regular visits to hemophilia patients, offering personalized care, monitoring treatment progress, and addressing any health concerns or complications.<\/p>

3.Patient Education:<\/strong> <\/em>HAL provides patients and their families with crucial information on managing hemophilia, preventing bleeding episodes, and adhering to treatment protocols.<\/p>

4. Support and Counseling:<\/strong> <\/em>Through outreach visits, HAL offers emotional support and counseling to help patients and families cope with the psychosocial aspects of living with hemophilia.<\/p>

These initiatives are aimed at enhancing treatment adherence, improving health outcomes, and ensuring holistic care for individuals with hemophilia and their families.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\n\t\t\t\t\t\t
\n\t\t\t\t\n\t\t\t\t\t\t\t\t<\/span>\n\t\t\t<\/div>\n\t\t\t\n\t\t\t\t\t\t
\n\n\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHOSPITAL OUTREACH\t\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/h3>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t

\n\t\t\t\t\t\tHAL\u2019s hospital outreach program in Lesotho aims to improve the diagnosis, treatment, and care of individuals with hemophilia, particularly in underserved areas with limited healthcare resources. Key components of the program include:\n
\n1.Training Healthcare Providers: <\/i><\/b>HAL offers specialized training to doctors, nurses, and healthcare professionals on diagnosing and managing hemophilia, ensuring they are equipped to provide effective care.\n
2.Access to Treatment: <\/i><\/b>The program works to ensure that essential clotting factor therapies are available and distributed to hemophilia patients across the country, especially in remote regions.\n
3.Early Diagnosis: <\/i><\/b>HAL supports local hospitals in improving diagnostic capabilities to enable early detection of hemophilia, preventing complications and enhancing patient outcomes.\n
4.Patient Education and Support: <\/i><\/b>HAL provides educational resources and support services to empower patients and their families, improving self-management and quality of life.\n
5.Collaboration with Local Health Authorities: <\/i><\/b>HAL partners with the Lesotho Ministry of Health to integrate hemophilia care into the national healthcare system, advocating for long-term improvements in treatment
and accessibility.\n\n
Through these initiatives, HAL seeks to strengthen the healthcare system in Lesotho, ensuring that individuals with hemophilia receive the necessary care and support.\t\t\t\t\t<\/p>\n\t\t\t\t\n\t\t\t<\/div>\n\t\t\t\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t
VON WILLEBRAND PATIENT VISIT<\/h6>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t

This visit was conducted as part of the World Federation of Hemophilia (WFH) Twinning Program, which connects clinics in resource-rich and resource-poor settings to improve care for patients with bleeding disorders. During this session, the patient and family were seen to assess the management of Von Willebrand Disease (VWD).<\/span><\/p>

Key Discussion Points:<\/span><\/strong><\/em><\/p>

1.Clinical Review:<\/strong><\/em>
– <\/strong><\/em>Bleeding History:<\/strong>Reviewed the patient\u2019s history of bleeding episodes (e.g., nosebleeds, heavy menstruation, joint bleeds).
–<\/strong><\/em>Current Treatment:<\/strong>Discussed current treatment plan (e.g., desmopressin or clotting factor replacement therapy) and its effectiveness.
–<\/strong><\/em>Lifestyle Impact:<\/strong>Focused on how VWD affects the patient\u2019s daily life, including school, activities, and potential risks for bleeding.<\/p>

2.Management Plan: <\/strong><\/em><\/p>

–<\/strong><\/em>Emphasized treatment adherence, including the importance of timely factor replacement or desmopressin use during bleeding episodes or before surgery.<\/span><\/p>

-Provided guidance on managing acute bleeding and when to seek medical help.<\/span><\/p>

3.Education for Patient & Family:<\/strong><\/em><\/p>

– Condition Overview:<\/strong> Educated the family about VWD and its genetic basis.
– Bleeding Prevention:<\/strong> Provided advice on preventing injuries, managing minor bleeding episodes, and recognizing early signs of more serious bleeds.
– Psychosocial Support:<\/strong> Discussed emotional and psychological aspects, supporting the patient and family with coping strategies, and shared local resources like support groups.<\/p>

5. Nearest Hemophilia Treatment Center (HTC):<\/strong>
– Informed the patient and family about the nearest Hemophilia Treatment Center (HTC) where they can access specialized care for bleeding disorders, including blood testing, treatment options, and emergency care.
– Provided the address and contact information for the HTC, as well as guidance on how to access care in case of an emergency or bleeding episode.<\/p>

The visit focused on reviewing the patient’s treatment plan, educating the family on VWD management, providing psychosocial support, and ensuring they have access to essential resources, including the nearest Hemophilia Treatment Center (HTC) for ongoing care. The WFH Twinning Program continues to provide valuable resources to improve care and ensure the patient and family are well-informed and supported in managing this chronic condition.<\/p><\/div><\/div>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t

\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t

OUTREACH IN PICTURES<\/h3>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\n\t\t\t\n\t\t\t\t\t\t
\n\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tVON WILLEBRAND PATIENT VISIT\t\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>\n\t\t\t\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\n\t\t\t\n\t\t\t\t\t\t
\n\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tHOSPITAL OUTREACH IN QUTHING\t\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>\n\t\t\t\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\n\t\t\t\n\t\t\t\t\t\t
\n\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t\n\t\t\t\t\t\t\tPATIENT OUTREACH\t\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/h5>\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/div>\n\t\t\t\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t\t
\"VON<\/figure><\/div>
\"IMG_6729\"<\/figure><\/div>
\"IMG-20220416-WA0023\"<\/figure><\/div>\t\t\t<\/div>\n\t\t\t\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t<\/path><\/svg>\t\t\t\t\t<\/div>\n\t\t\t\t\t
\n\t\t\t\t\t\t<\/path><\/svg>\t\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t\t\t\t\t\t
<\/div>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

OUTREACH As part of its commitment to improving the lives of individuals affected by hemophilia, HAL has implemented a series of targeted initiatives aimed at enhancing access to education and healthcare resources. These programs are designed to address the unique challenges faced by patients with hemophilia, healthcare professionals (HCPs), and other key stakeholders, particularly those […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-1107","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/haemophilia.org.ls\/index.php\/wp-json\/wp\/v2\/pages\/1107","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/haemophilia.org.ls\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/haemophilia.org.ls\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/haemophilia.org.ls\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/haemophilia.org.ls\/index.php\/wp-json\/wp\/v2\/comments?post=1107"}],"version-history":[{"count":28,"href":"https:\/\/haemophilia.org.ls\/index.php\/wp-json\/wp\/v2\/pages\/1107\/revisions"}],"predecessor-version":[{"id":1825,"href":"https:\/\/haemophilia.org.ls\/index.php\/wp-json\/wp\/v2\/pages\/1107\/revisions\/1825"}],"wp:attachment":[{"href":"https:\/\/haemophilia.org.ls\/index.php\/wp-json\/wp\/v2\/media?parent=1107"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}